Sarepta Therapeutics (SRPT) has significantly outperformed the market over the past decade, demonstrating the power of compounded returns. A $100 investment in SRPT 10 years ago would be worth over $500 today.
Results for: Compounded Returns
This article analyzes the impressive performance of Builders FirstSource (BLDR) over the past five years, highlighting its strong compounded returns and potential for future growth.
ConocoPhillips (COP) has consistently exceeded the market, generating an impressive 15.65% annualized return over the past five years. With a current market capitalization of $152.09 billion, COP continues to be a strong investment opportunity.